Fund
Gamma Bio Investors
Gamma Bio Investors took part in the round of Acta Pharmaceuticals (24 M$, seed) on 15 October 2026. It is the only health round Bolus has logged for it so far.
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 1
- Lead
- 0
- New entries
- 1
- Follow ons
- 0
- Latest operation
- 15 October 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 15 Oct | United States, Biotech | Seed | 24 M$ | Participant |
Co investors 2 funds crossed
Funds that appeared in the same rounds, in any capacity. Geographies logged: United States.